1. Home
  2. LUNG vs MACI Comparison

LUNG vs MACI Comparison

Compare LUNG & MACI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • MACI
  • Stock Information
  • Founded
  • LUNG 1995
  • MACI 2024
  • Country
  • LUNG United States
  • MACI United States
  • Employees
  • LUNG N/A
  • MACI N/A
  • Industry
  • LUNG Industrial Specialties
  • MACI
  • Sector
  • LUNG Health Care
  • MACI
  • Exchange
  • LUNG Nasdaq
  • MACI NYSE
  • Market Cap
  • LUNG 256.3M
  • MACI 218.2M
  • IPO Year
  • LUNG 2020
  • MACI 2024
  • Fundamental
  • Price
  • LUNG $6.36
  • MACI $10.12
  • Analyst Decision
  • LUNG Buy
  • MACI
  • Analyst Count
  • LUNG 6
  • MACI 0
  • Target Price
  • LUNG $11.92
  • MACI N/A
  • AVG Volume (30 Days)
  • LUNG 214.3K
  • MACI 19.2K
  • Earning Date
  • LUNG 02-19-2025
  • MACI 01-01-0001
  • Dividend Yield
  • LUNG N/A
  • MACI N/A
  • EPS Growth
  • LUNG N/A
  • MACI N/A
  • EPS
  • LUNG N/A
  • MACI N/A
  • Revenue
  • LUNG $79,302,000.00
  • MACI N/A
  • Revenue This Year
  • LUNG $22.26
  • MACI N/A
  • Revenue Next Year
  • LUNG $18.72
  • MACI N/A
  • P/E Ratio
  • LUNG N/A
  • MACI N/A
  • Revenue Growth
  • LUNG 22.34
  • MACI N/A
  • 52 Week Low
  • LUNG $5.46
  • MACI $9.95
  • 52 Week High
  • LUNG $14.84
  • MACI $10.18
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 41.35
  • MACI N/A
  • Support Level
  • LUNG $6.24
  • MACI N/A
  • Resistance Level
  • LUNG $7.27
  • MACI N/A
  • Average True Range (ATR)
  • LUNG 0.39
  • MACI 0.00
  • MACD
  • LUNG -0.06
  • MACI 0.00
  • Stochastic Oscillator
  • LUNG 2.52
  • MACI 0.00

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About MACI MELAR ACQUISITION CORP. I

Melar Acquisition Corp I is a blank check company.

Share on Social Networks: